What is Etoposide API powder?
Etoposide API powder, also known as etoposide raw material powder, is a semi synthetic scientific raw material derived from natural products. Its appearance is generally white or off white crystalline fine powder. The target of Etoposide API powder is topoisomerase II in cells, which can interfere with DNA repair during cell division and inhibit cell proliferation. Etoposide API powder is only used as an API raw material for testing related to scientific research and cannot be directly used for human or animal therapy. Raw material powder is not equivalent to finished injections or oral preparations, and direct contact and use will bring serious safety risks. It is strictly prohibited to use it directly as a drug.
Molecular Structure Characteristics of Etoposide API Powder
Etoposide API powder has a complex multi ring organic molecular skeleton, with its parent nucleus derived from podophyllotoxin. After artificial semi synthetic modification, the strong toxic groups of podophyllotoxin are removed, while the core active structure of targeted cell topoisomerase II is retained. The Etoposide API powder molecule contains multiple hydroxyl groups, which determine the binding ability between the molecule and the target protein, and also affect the solubility of Etoposide API powder in different solvents. Etoposide API powder has a low solubility in water and is soluble in some organic solvents. When preparing the solution system, it is necessary to choose a suitable solvent to ensure that Etoposide API powder is fully dispersed.
Etoposide API powder is stored in a sealed state away from light in a solid powder state, with relatively stable chemical properties and not easily decomposed quickly. However, the morphological stability of aqueous solutions is poor. Prolonged storage, exposure to light, or high temperature environments can alter the molecular structure of Etoposide API powder, leading to a decrease in activity. Therefore, the solution of Etoposide API powder needs to be prepared and used immediately to reduce storage time. After purification treatment, the impurity content of Etoposide API powder is strictly controlled, and the physical and chemical indicators fluctuate little between different production batches. The powder particles are uniform and suitable for building testing systems at various cellular levels.
The Etoposide API powder has a large molecular volume and requires the cell's own transport mechanism to enter the cell and exert its effects. MES-012 does not directly cleave DNA double strands, but instead locks onto a temporary complex formed by topoisomerase II and DNA to prevent DNA strand reconnection. This mode of action is significantly different from many materials that directly damage DNA. Etoposide API powder only works when cells enter a specific stage of division and has little effect on cells that are in a quiescent state.
The modifying groups on the molecular structure of Etoposide API powder determine its selectivity. Compared with the original podophyllotoxin, Etoposide API powder reduces non-specific damage to normal cells, but high concentration exposure still has an inhibitory effect on rapidly dividing normal cells. The binding ability of Etoposide API powder molecules is affected by the acidity and alkalinity of the system. Deviation from the appropriate pH range can weaken the binding efficiency between Etoposide API powder and the target enzyme DNA complex, reducing overall activity.
There are clear requirements for the storage conditions of Etoposide API powder, which requires it to be placed in a cool and dry environment, isolated from strong light, and avoid high temperatures. A humid environment can cause Etoposide API powder to become damp and clump, causing the molecules to slowly hydrolyze and the activity to gradually decrease. Properly stored Etoposide API powder can maintain its original physical and chemical properties for a long time, ensuring stable and reliable test data.
The principle of action of Etoposide API powder
When cells undergo division and replication, long DNA strands become tangled and knotted. The core function of topoisomerase II is to cut open double DNA strands, untangle the entanglement, and then reconnect the broken DNA strands to ensure smooth completion of DNA replication. After entering the cell, Etoposide API powder forms a stable ternary complex with topoisomerase II and DNA, which gets stuck at the site of DNA breakage and prevents the broken DNA strand from closing again.
DNA cracks cannot be repaired, and a large number of DNA double strand breaks continue to accumulate in cells. When cells perceive severe DNA damage, they will stop the process of cell division and cannot complete proliferation. When damage accumulates to a certain extent, cells will initiate programmed cell death pathways, ultimately losing their activity. Etoposide API powder only works on cells that are in the division cycle. Static cells do not replicate DNA, and topoisomerase II does not participate heavily in DNA processing. Therefore, Etoposide API powder is difficult to produce significant effects on these types of cells.
Etoposide API powder does not directly cause DNA breakage. It locks enzyme mediated DNA gaps to prevent repair, which is the core difference from many DNA damaging substances. If Etoposide API powder is removed from the system, some ternary complexes can dissociate, and cells still have the opportunity to repair DNA damage and restore proliferation ability. Therefore, the effect of action is directly related to the duration and concentration of raw material exposure. The higher the concentration, the more ternary complexes are formed inside the cell, the more severe the accumulation of DNA damage, and the stronger the inhibitory effect.
The sensitivity of different types of cells to Etoposide API powder varies greatly, and cells with faster proliferation rates are more susceptible to inhibition by Etoposide API powder. Some cells will gradually develop tolerance characteristics by changing the expression level of transport proteins, reducing the entry of Etoposide API powder into the cell, or enhancing DNA damage repair ability to reduce the impact of Etoposide API powder.
The inhibitory effect of Etoposide API powder is also influenced by the cell cycle status. Only when cells enter the S and G2 phases can topoisomerase II be activated in large quantities, and Etoposide API powder can fully exert its function. Cells in other stages of the cell cycle show a significant decrease in sensitivity to Etoposide API powder, which is also the reason why Etoposide API powder has a cycle dependent effect.
The main use of Etoposide API powder
Etoposide API powder is mainly used for building systems related to cell proliferation inhibition. It is used to observe the inhibitory effect of Etoposide API powder on the growth of various rapidly proliferating cells, record changes in cell morphology and proliferation rate, and explore suitable raw material concentrations and incubation times. During the activity testing process, Etoposide API powder is used to evaluate the survival status of cells after exposure to raw materials and obtain corresponding activity data.
Etoposide API powder can be used for observing DNA damage pathways, observing the expression changes of related proteins inside cells after Etoposide API powder causes DNA double strand breaks, and understanding the entire regulatory process of cell recognition of DNA damage, initiation of cell cycle arrest, and programmed cell death. By relying on Etoposide API powder, it is possible to intuitively observe the operational patterns of the DNA damage stress pathway.
Etoposide API powder is commonly used for cell resistance related validation, observing the process of cell tolerance after long-term exposure to Etoposide API powder, recording changes in the expression of transport proteins and DNA repair related proteins, exploring the underlying mechanisms of tolerance, and testing whether other substances can reverse the tolerance characteristics of cells to MES-012.
Etoposide API powder is often used as a standard reference material to compare the cell inhibitory ability of other new active substances, horizontally evaluate the activity strength of new materials, and provide a unified reference standard for screening new active materials. Standardized Etoposide API powder raw material batches can ensure horizontal comparison of data from different time periods and testing systems, reducing data bias caused by batch differences.
Etoposide API powder is only used as a research API raw material and cannot be directly formulated into drugs for human or animal use. The finished Etoposide formulation requires complex formulation processes and safety evaluations. The raw material powder has not undergone formulation processing, and direct use can bring serious risks such as bone marrow suppression and gastrointestinal damage. It is necessary to strictly distinguish between API raw materials and marketed drugs.
The cutting-edge development direction of Etoposide API powder
We will continue to explore targeted delivery carrier solutions around Etoposide API powder, using various carriers to encapsulate Etoposide API powder, enhancing its enrichment in target cells, reducing its contact with rapidly dividing normal cells, minimizing non-specific effects, and optimizing selectivity. Carrier modification can also improve the shortcoming of insufficient water solubility of Etoposide API powder and expand the range of usable systems.
The Etoposide API powder combination system is constantly being developed, which combines Etoposide API powder with other active substances targeting different targets to synergistically amplify the inhibitory effect on target cells, reduce the required concentration of Etoposide API powder used alone, alleviate the negative effects caused by high concentrations, and search for a synergistic combination ratio scheme.
We will continue to explore the issue of resistance to Etoposide API powder, search for auxiliary components that can block the cell resistance pathway, restore the sensitivity of drug-resistant cells to Etoposide API powder, overcome the problem of material efflux caused by overexpression of cell transporters, and provide new ideas for addressing cell tolerance.
The molecular modification of Etoposide API powder derivatives continues to advance, modifying functional groups on the basis of the original mother nucleus, optimizing the cellular uptake ability of molecules, reducing the probability of being excreted by cells, enhancing the activity of derivatives against cells that have already developed tolerance, and improving the existing shortcomings of Etoposide API powder.
Etoposide API powder continues to serve as a classic positive control material, widely used in various cell activity screening work, establishing a unified activity evaluation benchmark, facilitating the assessment of the strength of various new active substances, and maintaining comparability of data between different testing systems.
Conclusion
Etoposide API powder is a semi-synthetic research-grade active pharmaceutical ingredient (API) that targets topoisomerase II; it inhibits rapidly proliferating cells by stabilizing the DNA-enzyme ternary complex and blocking DNA strand repair. Characterized by limited water solubility and cell-cycle-dependent activity, it is widely used in research concerning the inhibition of cell proliferation, DNA damage pathways, and drug resistance. As an API raw material, it cannot be administered directly as a finished drug; current research efforts involving Etoposide API powder focus on optimizing delivery systems, developing combination formulations, and engineering derivatives.
Xi'an Faithful BioTech Co., Ltd. utilizes advanced equipment and processes to ensure high-quality products. Our Etoposide API powder meets international pharmaceutical standards. Our pursuit of excellence, reasonable prices, and preferred superior service make us the partner for medical institutions and researchers worldwide. If you require Etoposide research or production,Please contact us Click email: allen@faithfulbio.com Or WhatsApp: +86 13137770562.
FAQ
Q1: Does Etoposide API powder kill cells directly?
A: Etoposide API powder does not directly destroy cells; instead, it inhibits DNA repair, leading to an accumulation of DNA damage. This triggers the cell's own programmed cell death mechanisms, ultimately resulting in the loss of cell viability.
Q2: What is the target of Etoposide API powder?
A: Etoposide API powder targets topoisomerase II; it stabilizes the complex formed between topoisomerase II and DNA, thereby preventing the re-ligation of broken DNA strands.
Q3: Can Etoposide API powder be administered directly?
A: No. Etoposide API powder is merely the active pharmaceutical ingredient (API) in powder form; it has not undergone pharmaceutical formulation or safety assessment. Direct use would result in severe toxicity, and it cannot be used directly as a finished drug product.
References
- Wozniak, A. J., & Ross, W. E. (1983). Etoposide: Mechanism of action. Pharmacology & Therapeutics, 22(3), 327–347.
- Liu, L. F. (1989). DNA topoisomerase poisons as antitumor drugs. Annual Review of Biochemistry, 58(1), 351–375.
- Hande, K. R. (1998). Etoposide: Four decades of development of a topoisomerase II inhibitor. European Journal of Cancer, 34(10), 1514–1521.
- Chen, A. Y., & Liu, L. F. (1994). DNA topoisomerases: Essential enzymes and targets of therapeutic agents. Annual Review of Pharmacology and Toxicology, 34(1), 191–218.
- Sinha, B. K. (1995). Etoposide: Mechanisms of resistance. Cancer Chemotherapy and Pharmacology, 36(Suppl), S78–S82.
- Makin, G., & Hickman, J. A. (2000). Apoptosis and cancer chemotherapy. Cell and Tissue Research, 301(1), 143–152.
- Greer, S., & Peterson, R. (1982). Etoposide pharmacology. Seminars in Oncology, 9(4 Suppl 1), 3–10.
